Vertex Pharmaceuticals (VRTX)
$180.18 4.06 (2.20%)
17:48 EDT VRTX Stock Quote Delayed 15 Minutes
Previous Close $180.18
Market Cap 45.92B
PE Ratio 209.51
Volume (Avg. Vol.) 1.20M
Day's Range 179.24 - 186.78
52-Week Range 151.80 - 195.81
Dividend & Yield N/A (N/A)
VRTX Stock Predictions, Articles, and Vertex Pharmaceuticals News
- From InvestorPlace
- From the Web
Growth is on a different track now, and here are some great ideas for stocks to buy to ride the momentum.
The long term is rosy for these five biotech stocks. They have the pipelines, partners and marketed drugs to provide years of growth for investors.
The stock charts of HollyFrontier, Activision Blizzard and Vertex Pharmaceuticals are poised to end the trading week in a pivotal situation.
Even in these unstable times, there are still gems to be found. And these are 10 of the hottest stocks on the Street, complete with "strong buy" analyst ratings and some compelling growth drivers.
Stock charts of VRTX, NKTR and SYMC are going to end the trading week knocking on the door of major moves.
Government is scrutinizing the drug development and approval process and creating uncertainties among biotech stocks. Time to buy?
One of the best mutual funds last year was the T. Rowe Price Health Sciences Fund. Here are 7 healthcare stocks to buy from its holdings.
Put these fast-growing stocks on your radar, if not in your portfolio, as your best shot at overcoming the market's summertime blues.
The market volatility isn't all bad! Now investors can find stocks to buy at killer entry points --determined by the Street's stop analysts.
Morgan Stanley says these stocks are set to outperform even if the market slows down in 2019. That makes these 10 excellent stocks to buy for careful investors.
These four stocks are among the best U.S. stocks to buy today, as they beat S&P 500 growth rates in the past and should maintain strong growth rates in the years ahead.
Here are stocks that will be undeterred by volatility. All 10 have momentum, earnings and sales on their side right now.
3 Stocks to Watch on Thursday: Mondelez International Inc (MDLZ), Paypal Holdings Inc (PYPL) and Vertex Pharmaceuticals Incorporated (VRTX)
Mondelez (MDLZ) beat earnings expectations, Paypal (PYPL) revenue grew 24% and Vertex Pharmaceuticals' (VRTX) adjusted income up 74%.
The big winners for 2017 range from dentistry to energy to tech, and the biggest tech winners are based far from Silicon Valley.
Currently, Vertex Pharmaceuticals Inc (NASDAQ:VRTX) has a Buy using the stock evaluator from Portfolio Grader, which incorporates Louis Navellier's investing approach. This represents no change from the previous week and is the same ranking VRTX has had from Portfolio Grader for 4 months.
Navellier RatingsPowered by Portfolio Grader
10 Stocks Set for Monster Growth
He found Apple at $4… Oracle at $6… Amazon at $40… Now legendary growth investor Louis Navellier is giving away his latest Research Report — for FREE!
Download your FREE COPY!